Akari Therapeutics (AKTX) Deferred Taxes (2025 - 2026)
Akari Therapeutics (AKTX) posted quarterly Deferred Taxes of -$859000.0 for Q1 2026, down 178.95% on a QoQ basis from $1.1 million in Q3 2025.
Akari Therapeutics (AKTX) Deferred Taxes (2025 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has reported Deferred Taxes for 2 consecutive years, with -$859000.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - | -859,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -859,000.00 |
| Sep 30, 2025 | 1.09 Mn |